Evidence map›Paper›PMID 40522907›Full record

ArticlePloS one2025

Study on the aging performance of SBS modified asphalt in humid and hot environment.

Xiaoyan Liu, Ping Li, Jingsheng Pan

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoyan LiuDepartment of Civil Engineering, Chengdu Technological University, Yibin, China.
Ping LiDepartment of Civil Engineering, Chengdu Technological University, Yibin, China.
Jingsheng PanDepartment of Civil Engineering, Chengdu Technological University, Yibin, China.ORCID 0009-0003-4020-0445

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study focused on the aging issues of asphalt pavement in high-temperature and high-humidity climatic zones, using SBS-modified asphalt with different additive contents as research objects to systematically investigate the aging evolution mechanisms under coupled hygrothermal conditions. A dual-temperature control system (60°C and 70°C) was constructed to conduct thermal-oxidative aging and wet-dry cycle aging tests. Multidimensional indicators including penetration ratio, softening point ratio, and ductility ratio were utilized to characterize the time-dependent aging characteristics of materials. Additionally, dynamic shear rheology (DSR) tests and rutting tests were integrated to comprehensively evaluate the high-temperature performance degradation of asphalt and its mixtures with varying modifier contents under cyclic aging. The research aimed to reveal the hygrothermal-coupled aging mechanisms and provide theoretical foundations for durable pavement design in humid tropical regions. Experimental results demonstrated that after thermal-oxidative and wet-dry cycle aging at 60°C and 70°C, the performance indices of SBS-modified asphalt with different additive contents deteriorated significantly. Specifically, the penetration ratio decreased by an average of 29.1%, the ductility ratio declined by 14.6%, and the softening point ratio increased by 60.3%. Concurrently, high-temperature rheological performance exhibited progressive degradation. Notably, increased SBS modifier content was observed to mitigate the aging-induced performance attenuation of modified asphalt. Analytical findings suggested that while higher SBS content enhanced structural stability to some extent, the presence of elevated temperature and moisture accelerated the degradation of SBS modifiers and the aging of base asphalt, thereby exacerbating the overall aging of modified asphalt and leading to performance deterioration.

Indexed as

Construction MaterialsHot TemperatureHumidityHydrocarbonsRheologyasphaltHydrocarbons

Identifiers

PMID40522907
PMCPMC12169586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.